A major breakthrough in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This crucial malignant inhibitor protein is frequently lost in several kinds of cancer, leading uncontrolled https://bookmarkfavors.com/story7686896/mini-antibodies-revive-p53-the-new-hope-for-cancer-treatment